News

Search Articles

91 - 100 of 100 Results Clear All

Article April 25, 2012

Gladstone Scientists Identify Key Network Mechanism That Could Contribute to Cognitive Problems in Alzheimer’s Disease

SAN FRANCISCO, CA—April 26, 2012—Scientists at the Gladstone Institutes have unraveled a process by which depletion of a specific protein in the brain contributes to the memory problems associated with Alzheimer's disease.

Alzheimer’s Disease

Article April 2, 2012

Gladstone Scientists Find Increased ApoE Protein Levels May Promote Alzheimer’s Disease

SAN FRANCISCO, CA—Scientists at the Gladstone Institutes have enhanced our understanding of how a protein linked to Alzheimer's disease keeps young brains healthy, but can damage them later in life—suggesting new research avenues for treating this devastating disease.

Alzheimer’s Disease

Article July 13, 2011

Gladstone to Speed Drug Development with Center for Comprehensive Alzheimer’s Disease Research

SAN FRANCISCO, CA—July 14, 2011—The Gladstone Institutes today announced plans to create a Center for Comprehensive Alzheimer's Disease Research, offering new hope for the millions of families stricken by this debilitating neurodegenerative disease.

Alzheimer’s Disease

Article April 28, 2011

Hellman Family Foundation Gives $1M to Gladstone for Alzheimer’s Disease Research

SAN FRANCISCO, CA—April 29, 2011—The Hellman Family Foundation has donated $1 million to the Gladstone Institutes to help spur the development of medications for Alzheimer's disease.

Alzheimer’s Disease

Article November 27, 2010

Gene Therapy Prevents Memory Problems in Mice with Alzheimer’s Disease

SAN FRANCISCO, CA—Scientists at the Gladstone Institute of Neurological Disease (GIND) in San Francisco have discovered a new strategy to prevent memory deficits in a mouse model of Alzheimer's disease.

Alzheimer’s Disease Mucke Lab

Article October 12, 2010

Gladstone Scientists Uncover Novel Mechanism for the Major Genetic Risk Factor of Alzheimer’s Disease

SAN FRANCISCO, CA—Alzheimer's disease is an extremely complicated disease. Several proteins seem to be involved in its cause and progression.

Alzheimer’s Disease Huang Lab

September 8, 2010

Strategy Discovered to Prevent Alzheimer-associated Traffic Jams in the Brain

SAN FRANCISCO, CA—Amyloid beta (Αβ) proteins, widely thought to cause Alzheimer's disease, block the transport of vital cargoes inside brain cells.

Alzheimer’s Disease Mucke Lab

Article February 17, 2010

Gladstone’s Lennart Mucke Wins Potamkin Prize for Identifying New Avenues in Alzheimer’s Research

SAN FRANCISCO, CA—February 18, 2010—Lennart Mucke, MD, Director of the Gladstone Institute of Neurological Disease (GIND), has been named a recipient of the American Academy of Neurology's prestigious Potamkin Prize.

Awards Alzheimer’s Disease

Article December 2, 2009

Gladstone Scientists Identify Strategies To Protect New Brain Cells Against Alzheimer’s Disease

SAN FRANCISCO, CA—Stimulating the growth of new neurons to replace those lost in Alzheimer's disease (AD) is an intriguing therapeutic possibility. But will the factors that cause AD allow the new neurons to thrive and function normally?

Alzheimer’s Disease Gan Lab Huang Lab

Article January 6, 2009

A Special Type of Collagen May Help Protect the Brain Against Alzheimer’s Disease

SAN FRANCISCO, CA—Scientists from the Gladstone Institute of Neurological Disease (GIND), UCSF, and Stanford have discovered that a certain type of collagen, collagen VI, protects brain cells against amyloid-beta (Aβ) proteins, which are widely thought to cause Alzheimer's disease.

Alzheimer’s Disease Mucke Lab

Are You a Journalist Looking to Write about Gladstone?

Explore Info for Media

Gladstone Scientists Identify Key Network Mechanism That Could Contribute to Cognitive Problems in Alzheimer’s Disease

Gladstone Scientists Identify Key Network Mechanism That Could Contribute to Cognitive Problems in Alzheimer’s Disease

Gladstone Scientists Find Increased ApoE Protein Levels May Promote Alzheimer’s Disease

Gladstone Scientists Find Increased ApoE Protein Levels May Promote Alzheimer’s Disease

Gladstone to Speed Drug Development with Center for Comprehensive Alzheimer’s Disease Research

Gladstone to Speed Drug Development with Center for Comprehensive Alzheimer’s Disease Research

Hellman Family Foundation Gives $1M to Gladstone for Alzheimer’s Disease Research

Hellman Family Foundation Gives $1M to Gladstone for Alzheimer’s Disease Research

Gene Therapy Prevents Memory Problems in Mice with Alzheimer’s Disease

Gene Therapy Prevents Memory Problems in Mice with Alzheimer’s Disease

Gladstone Scientists Uncover Novel Mechanism for the Major Genetic Risk Factor of Alzheimer’s Disease

Gladstone Scientists Uncover Novel Mechanism for the Major Genetic Risk Factor of Alzheimer’s Disease

Strategy Discovered to Prevent Alzheimer-associated Traffic Jams in the Brain

Strategy Discovered to Prevent Alzheimer-associated Traffic Jams in the Brain

Gladstone’s Lennart Mucke Wins Potamkin Prize for Identifying New Avenues in Alzheimer’s Research

Gladstone’s Lennart Mucke Wins Potamkin Prize for Identifying New Avenues in Alzheimer’s Research

Gladstone Scientists Identify Strategies To Protect New Brain Cells Against Alzheimer’s Disease

Gladstone Scientists Identify Strategies To Protect New Brain Cells Against Alzheimer’s Disease

A Special Type of Collagen May Help Protect the Brain Against Alzheimer’s Disease

A Special Type of Collagen May Help Protect the Brain Against Alzheimer’s Disease

Are You a Journalist Looking to Write about Gladstone?

Stay up to date with us

Congrats to Jennifer Doudna, winner of the 2020 Nobel Prize in Chemistry!